How big is Clade Therapeutics Inc.'s plan?

Clade Therapeutics Inc.'s plan reported $2.2M in assets and 66 participants for 2023.

Original filing (PDF)20240606083354NAL0021930721001

Clade Therapeutics Inc.

Name: Clade Therapeutics Inc. — Clade Therapeutics Inc., Form 5500 (2023)
Creator: Clade Therapeutics Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Clade Therapeutics Inc. 401(k) Plan

401(k) retirement plan · Clade Therapeutics Inc.'s Clade Therapeutics Inc. 401(k) Plan held $2.2M in plan assets for 66 participants in 2023.

Active participants

Accounts w/ balance

Plan assets (EOY)

$2.2M

Net assets (EOY)

$2.2M

People on this filing

Laura Langner signed Clade Therapeutics Inc.'s 2023 Form 5500 as plan administrator.

Laura Langner — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Clade Therapeutics Inc.'s EIN is 85-3881133.

EIN 85-3881133

Plan number 001

Plan year 2023

ACK ID 20240606083354NAL0021930721001

Official Form 5500 document

Download the official 2023 Form 5500 (PDF) for Clade Therapeutics Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2023 Form 5500 (PDF)

Plan features

Clade Therapeutics Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, automatic enrollment, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for CLADE THERAPEUTICS INC.

Finding similar companies…

Plan health score

Above-average plan

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score